Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.38 billion in 2021. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: We want to improve life today and tomorrow.
Year founded2007
Served areaWorldwide
Headcount33,106
HeadquartersRellinghauser Straße 1-11, 45128 Essen – Germany
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
28.11.23 | Schuh, Maike | Board | Buy | EUR 30,042.10 |
07.06.23 | Baur, Dr. Cornelius | Supervisory board | Buy | EUR 250,021.90 |
05.06.23 | Kullmann, Christian | Board | Buy | EUR 99,697.30 |
05.06.23 | Wessel, Thomas | Board | Buy | EUR 53,286.00 |
05.06.23 | Schuh, Maike | Board | Buy | EUR 49,998.68 |
28.03.23 | Wessel, Thomas | Board | Buy | EUR 49,655.75 |
19.12.22 | Wessel, Thomas | Board | Buy | EUR 54,075.00 |
14.11.22 | Kullmann, Christian | Board | Buy | EUR 99,090.75 |
01.07.21 | Lorenz-Meyer, Robert | Supervisory board | Sell | EUR 234,540.92 |
30.06.21 | Wessel, Thomas | Board | Buy | EUR 19,810.00 |
DE000EVNK013
LEI41GUOJQTALQHLF39XJ34
SectorCommerzbank AG
Listed Stock ExchangeMDAX
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.